$5 million cooperative agreement from the National Institutes of Health awarded to advance the development of its breakthrough non-invasive device, MyoRegulator™ for treatment of spasticity Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
ABL will manufacture another oncolytic virus therapy for SillaJen (JX-970) in an expanded partnership to advance development of SillaJen's oncolytic immunotherapy products against cancer. Read More
Asymmetrex co-sponsors Nov. 30 online RegMedNet expert panel on the state of knowledge for production and characterization of tissue stem cells used in approved therapies and experimental treatments. Read More
Seyfarth Shaw LLP announced today that Dean Fanelli, Ph.D. and Thomas Haag, Ph.D., co-founders of top intellectual property boutique Fanelli Haag PLLC, have joined Seyfarth as partners in the Litigati Read More
Two years ago, Asymmetrex announced a first-ever technology for counting adult tissue stem cells. Now, the company reveals how counting can increase therapeutic stem cell production at reduced cost. Read More
AstraZeneca is reinvesting a further A$100 million to expand its manufacturing facility in North Ryde, Sydney. Read More